vancomycin has been researched along with mometasone furoate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Abrassart, S; Assal, M; Bernard, L; Djordjevic, M; Ferry, T; Roussos, C; Uçkay, I; Vaudaux, P; Vauthey, L | 1 |
Basaraba, RJ; Jabra-Rizk, MA; Khoueir, N; Leid, JG; Shikani, AH; Shikani, HJ | 1 |
4 other study(ies) available for vancomycin and mometasone furoate
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Vancomycin-induced DRESS syndrome in a female patient.
Topics: Acute Kidney Injury; Anti-Allergic Agents; Anti-Bacterial Agents; Drug Eruptions; Eosinophilia; Female; Fever; Glucocorticoids; Humans; Methylprednisolone; Middle Aged; Mometasone Furoate; Pregnadienediols; Syndrome; Vancomycin | 2008 |
Topical therapy for refractory rhinosinusitis caused by methicillin-resistant Staphylococcus aureus: First report in a prospective series.
Topics: Administration, Intranasal; Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cellulose; Culture Techniques; Debridement; Endoscopy; Female; Humans; Instillation, Drug; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Mometasone Furoate; Mupirocin; Nebulizers and Vaporizers; Prospective Studies; Rhinitis; Saline Solution; Sinusitis; Staphylococcal Infections; Therapeutic Irrigation; Tobramycin; Treatment Outcome; Vancomycin | 2018 |